Veterinary Medicines

Panacur vet. granulat 222 mg/g

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Panacur vet. granulat 222 mg/g
Active substance:
  • Fenbendazole
Target species:
  • Cattle
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    222.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        4
        day
    • Horse
      • Meat and offal
        14
        day
      • Milk
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 00-06263
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 16/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 16/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."